NO972614D0 - Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur - Google Patents

Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur

Info

Publication number
NO972614D0
NO972614D0 NO972614A NO972614A NO972614D0 NO 972614 D0 NO972614 D0 NO 972614D0 NO 972614 A NO972614 A NO 972614A NO 972614 A NO972614 A NO 972614A NO 972614 D0 NO972614 D0 NO 972614D0
Authority
NO
Norway
Prior art keywords
pct
mixture
micelle
composition
normal
Prior art date
Application number
NO972614A
Other languages
English (en)
Other versions
NO972614L (no
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of NO972614D0 publication Critical patent/NO972614D0/no
Publication of NO972614L publication Critical patent/NO972614L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1274Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
NO972614A 1994-12-09 1997-06-06 Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur NO972614L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9404289A SE518619C2 (sv) 1994-12-09 1994-12-09 Komposition för reglerad frisättning innehållande monokaproin
PCT/SE1995/001479 WO1996017597A1 (en) 1994-12-09 1995-12-08 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure

Publications (2)

Publication Number Publication Date
NO972614D0 true NO972614D0 (no) 1997-06-06
NO972614L NO972614L (no) 1997-06-06

Family

ID=20396276

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972614A NO972614L (no) 1994-12-09 1997-06-06 Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur

Country Status (13)

Country Link
US (1) US5906831A (no)
EP (1) EP0790822B1 (no)
JP (1) JP3487860B2 (no)
AT (1) ATE213932T1 (no)
AU (1) AU4276896A (no)
BR (1) BR9509897A (no)
CA (1) CA2207218C (no)
DE (1) DE69525761T2 (no)
ES (1) ES2170171T3 (no)
FI (1) FI972415A0 (no)
NO (1) NO972614L (no)
SE (1) SE518619C2 (no)
WO (1) WO1996017597A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
JP2005507754A (ja) * 2001-11-08 2005-03-24 アトリウム メディカル コーポレイション 治療薬を含有するコーティングを有する管腔内装置
DK1460992T3 (da) * 2001-12-03 2009-06-22 Dor Biopharma Inc Stabiliserede omvendte micellesammensætninger og anvendelser deraf
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
EP1804717A4 (en) * 2004-09-28 2015-11-18 Atrium Medical Corp DRUG DELIVERY COATING WHICH CAN BE USED WITH VASCULAR ENDOPROSTHESIS
US8124127B2 (en) 2005-10-15 2012-02-28 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036969A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Formation of barrier layer
US20060083768A1 (en) * 2004-09-28 2006-04-20 Atrium Medical Corporation Method of thickening a coating using a drug
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US7670997B2 (en) * 2006-06-08 2010-03-02 Bausch & Lomb Incorporated Ophthalmic compositions comprising a branched, glycerol monoalkyl compound and a fatty acid monoester
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
EP2083875B1 (en) 2006-11-06 2013-03-27 Atrium Medical Corporation Coated surgical mesh
KR101522747B1 (ko) 2007-08-06 2015-05-26 알레간 인코포레이티드 데스모프레신 약물 전달을 위한 방법 및 장치
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
PT2712622T (pt) * 2008-05-21 2016-10-13 Ferring Bv Desmopressina orodispersível para aumentar o período inicial de sono tranquilo
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
US9744542B2 (en) 2013-07-29 2017-08-29 Apeel Technology, Inc. Agricultural skin grafting
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
JP7157531B2 (ja) 2015-05-20 2022-10-20 アピール テクノロジー,インコーポレイテッド 植物抽出物組成物およびその調製方法
US10266708B2 (en) 2015-09-16 2019-04-23 Apeel Technology, Inc. Precursor compounds for molecular coatings
ES2797697T3 (es) 2015-12-10 2020-12-03 Apeel Tech Inc Proceso para despolimerizar cutina
EP3407713A1 (en) 2016-01-26 2018-12-05 Apeel Technology, Inc. Method for preparing and preserving sanitized products
CN110087475B (zh) 2016-11-17 2023-04-11 阿比尔技术公司 由植物提取物形成的组合物及其制备方法
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
WO2021178553A1 (en) 2020-03-04 2021-09-10 Apeel Technology, Inc. Coated agricultural products and corresponding methods
MX2023004343A (es) 2020-10-30 2023-05-08 Apeel Tech Inc Composiciones y metodos de preparacion de las mismas.
CN116456961A (zh) * 2020-11-04 2023-07-18 伊诺莱克斯投资公司 生物基甘油庚酸酯组合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
SE457693B (sv) * 1986-07-01 1989-01-23 Drilletten Ab Komposition med reglerad frigoering vari ett biologiskt material aer loest eller dispergerat i en l2-fas

Also Published As

Publication number Publication date
JPH10510260A (ja) 1998-10-06
DE69525761T2 (de) 2002-10-24
FI972415A (fi) 1997-06-06
JP3487860B2 (ja) 2004-01-19
ES2170171T3 (es) 2002-08-01
SE518619C2 (sv) 2002-10-29
ATE213932T1 (de) 2002-03-15
AU4276896A (en) 1996-06-26
FI972415A0 (fi) 1997-06-06
US5906831A (en) 1999-05-25
DE69525761D1 (de) 2002-04-11
EP0790822B1 (en) 2002-03-06
NO972614L (no) 1997-06-06
BR9509897A (pt) 1997-12-30
WO1996017597A1 (en) 1996-06-13
CA2207218A1 (en) 1996-06-13
CA2207218C (en) 2002-02-12
SE9404289L (sv) 1996-06-10
EP0790822A1 (en) 1997-08-27
SE9404289D0 (sv) 1994-12-09

Similar Documents

Publication Publication Date Title
NO972614D0 (no) Preparat med kontrollert frigivelse som danner en reversert micelle (L2)-struktur eller en normal micelle (L1)-struktur
MX9200554A (es) Composicion analgesica topica y procedimiento para su preparacion
ES2134360T3 (es) Formulaciones de perfume.
SE9103783L (sv) Vaermebestaendig chokladkomposition och foerfarande foer framstaellning daerav
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
NO166682C (no) Insekticid preparat omfattende en blanding av pyrethroider, anvendelse derav som insekticid, og fremgangsmaate til fremstilling av blandingen.
BR9916225A (pt) Composição
BRPI0409831A (pt) composição de condicionamento de tecidos, e, uso de um material não iÈnico
ATE99924T1 (de) Amphipatische emulgiermittel enthaltende emulsionzusammensetzungen.
ATE133867T1 (de) Verfahren zur herstellung eines durch einbau einer lipophilen wirksubstanz modifizierten lipoproteins
EA200300630A1 (ru) Жидкая композиция для жарки
DE3478029D1 (en) Biopolymer compositions and process for their preparation
KR880000134A (ko) 수중유 유탁액의 제조방법
HRP20060040A2 (en) PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS
DE60016732D1 (de) Alkanolamid-tensid-emulsionen und deren herstellung
KR890013166A (ko) 세제 조성물
KR940006488A (ko) 영양 조성물 및 이의 제조방법
KR830008487A (ko) 에멀션 제초제(Synergistic Herbicide Emulsion)
KR920021694A (ko) 친수성 무공해 광택제의 조성방법
ATE296443T1 (de) Zusammensetzung und herstellung einer standardprobe
RU92010882A (ru) Состав для разработки нефтяных месторождений
KR870008584A (ko) 피임제 조성물
AR001341A1 (es) Composición coadyuvante líquida de uso agricola.
KR920007538A (ko) 벤푸레세이트 및 다임론을 기재로 하는 제초 조성물

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application